Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hormone Refractory”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01631552
What this trial is testing

Study of Sacituzumab Govitecan-hziy (IMMU-132) in Adults With Epithelial Cancer

Who this might be right for
Gastric AdenocarcinomaEsophageal CancerHepatocellular Carcinoma+13 more
Gilead Sciences 515
Testing effectiveness (Phase 2)Study completedNCT00583024
What this trial is testing

Phase II Study of Adenovirus/PSA Vaccine in Men With Hormone - Refractory Prostate Cancer

Who this might be right for
Hormone Refractory Prostate Cancer
David M Lubaroff 32
Testing effectiveness (Phase 2)Study completedNCT00268710
What this trial is testing

Docetaxel in Hormone Refractory Prostate Cancer (HRPC)[Weekly or 3weekly TAX + Prednisone in HRPC]

Who this might be right for
Prostatic Neoplasms
Sanofi
Testing effectiveness (Phase 2)Study completedNCT00667199
What this trial is testing

BAY88-8223, Does Response Study in HRPC Patients

Who this might be right for
Hormone Refractory Prostate CancerBone Metastases
Bayer 100
Large-scale testing (Phase 3)Study completedNCT00127478
What this trial is testing

A Long Term Safety Study With Atrasentan

Who this might be right for
Prostate CancerAdenocarcinoma
Abbott 166
Not applicableUnknownNCT02208583
What this trial is testing

Molecular Phenotype Changes and Personalized Treatment for CRPC

Who this might be right for
Hormone Refractory Prostate Cancer
Tianjin Medical University Cancer Institute and Hospital 150
Testing effectiveness (Phase 2)Study completedNCT00723086
What this trial is testing

Japanese Study of the Combined Administration of Docetaxel With Prednisolone for Metastatic Hormone Refractory Prostate Cancer

Who this might be right for
Therapy, Prostatic Neoplasms
Sanofi 16
Testing effectiveness (Phase 2)Study completedNCT00016107
What this trial is testing

Combination Chemotherapy Plus Bevacizumab in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateHormone-resistant Prostate CancerRecurrent Prostate Cancer+1 more
National Cancer Institute (NCI) 72
Testing effectiveness (Phase 2)Study completedNCT00570700
What this trial is testing

Trial of Dasatinib (Sprycel®) in Subjects With Hormone-refractory Prostate Cancer

Who this might be right for
Hormone-refractory Prostate CancerAdenocarcinoma of the ProstateHormone-resistant Prostate Cancer+2 more
University of California, Irvine 38
Testing effectiveness (Phase 2)Study completedNCT00286793
What this trial is testing

Safety and Efficacy Study of AT-101 in Combination With Docetaxel and Prednisone in Men With HRPC

Who this might be right for
Prostate Cancer
Ascenta Therapeutics 76
Testing effectiveness (Phase 2)Study completedNCT00636740
What this trial is testing

Multi-Center Phase II Study to Compare MER-101 20mg Tablets to Intravenous Zometa 4mg in Male Bisphosphonate-Naive, Hormone Refractory Prostate Cancer Patients

Who this might be right for
Hormone-Refractory Prostate Cancer
Merrion Pharmaceuticals, LLC 30
Testing effectiveness (Phase 2)Ended earlyNCT00503984
What this trial is testing

A Phase I/II Study of Azacitidine, Docetaxel, and Prednisone for Metastatic Prostate Cancer Patients

Who this might be right for
Prostate CancerPain
University of Miami 22
Testing effectiveness (Phase 2)Ended earlyNCT00452387
What this trial is testing

Mitoxantrone, Prednisone Plus Sorafenib in Taxane-Refractory Metastatic Hormone Refractory Prostate Cancer (HRPC)

Who this might be right for
Metastatic Prostate Cancer
Accelerated Community Oncology Research Network 22
Testing effectiveness (Phase 2)Study completedNCT00394810
What this trial is testing

Efficacy and Pharmacodynamic Study of Panzem® NCD in Patients With Hormone-Refractory Prostate Cancer

Who this might be right for
Prostate Cancer
CASI pharmaceuticals, Inc. 21
Testing effectiveness (Phase 2)Ended earlyNCT00633087
What this trial is testing

A Phase I/II Trial of 2-Deoxyglucose (2DG) for the Treatment of Advanced Cancer and Hormone Refractory Prostate Cancer

Who this might be right for
Prostate Cancer
Rutgers, The State University of New Jersey 12
Large-scale testing (Phase 3)Study completedNCT00069745
What this trial is testing

Satraplatin in Hormone Refractory Prostate Cancer Patients Previously Treated With One Cytotoxic Chemotherapy Regimen

Who this might be right for
Prostate CancerHormone Refractory Prostate Cancer
Agennix
Not applicableUnknownNCT04808856
What this trial is testing

Treatment of Refractory Gout With ACTH or Methylprednisolone

Who this might be right for
Gout
Shanghai 10th People's Hospital 60
Large-scale testing (Phase 3)Study completedNCT01618370
What this trial is testing

Radium(223) Dichloride (Alpharadin) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases

Who this might be right for
Prostatic Neoplasms
Bayer 705
Testing effectiveness (Phase 2)Study completedNCT00156884
What this trial is testing

A Trial of Strontium +/- Cisplatin for the Palliation of Bone Pain Secondary to Hormone Refractory Prostate Cancer

Who this might be right for
Hormone Refractory Prostate CancerBone Metastases
Alberta Health services 58
Testing effectiveness (Phase 2)Study completedNCT00928252
What this trial is testing

Chemotherapy Response Monitoring With 18F-choline PET/CT in Hormone Refractory Prostate Cancer

Who this might be right for
Hormone Refractory Prostate Cancer
Queen's Medical Center 25
Next Page